Cargando…

Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters

INTRODUCTION: Benefits of disease-modifying anti-rheumatic drugs (DMARD) in early rheumatoid arthritis patients (ERAP) will be achieved if patients follow prescribed treatment. Objective was to investigate whether timing of first non-persistence period and/or duration of persistence during the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	Contreras-Yáñez, Irazú, Pascual-Ramos, Virginia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499189/ https://www.ncbi.nlm.nih.gov/pubmed/26162892 http://dx.doi.org/10.1186/s13075-015-0697-z

Ejemplares similares

Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient’s perspective
por: Pascual-Ramos, Virginia, et al.
Publicado: (2013)

Predictors of health care drop-out in an inception cohort of patients with early onset rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017)

Patient’s perspective of sustained remission in rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017)

Validation of a risk perception questionnaire developed for patients with rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2019)

Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability
por: Pascual-Ramos, Virginia, et al.
Publicado: (2009)

Early persistence on therapy impacts drug-free remission: a case-control study in a cohort of Hispanic patients with recent-onset rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2022)

Psychometric validation of an empowerment scale for Spanish-speaking patients with rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2018)

Markers of disease severity and positive family history are associated to significant risk perception in rheumatoid arthritis, while compliance with therapy is not: a cross-sectional study in 415 Mexican outpatients
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2021)

Patient and physician perspectives of hand function in a cohort of rheumatoid arthritis patients: the impact of disease activity
por: Romero-Guzmán, Ana K., et al.
Publicado: (2016)

Development and validation of a questionnaire assessing household work limitations (HOWL-Q) in women with rheumatoid arthritis
por: Ortiz-Haro, Ana Belén, et al.
Publicado: (2020)

Early referral and control of disease’s flares prevent Orthopedic and Hand Surgery Indication (OHSI) in a dynamic cohort of Hispanic early rheumatoid arthritis patients
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2018)

Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity
por: Parra-Salcedo, Federico, et al.
Publicado: (2015)

The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: A multivariable analysis
por: Galindo-Donaire, José R., et al.
Publicado: (2023)

Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters Function
por: Atisha-Fregoso, Yemil, et al.
Publicado: (2016)

Views of Mexican outpatients with rheumatoid arthritis on sexual and reproductive health: A cross-sectional study
por: Ledón-LLanes, Loraine, et al.
Publicado: (2021)

Association of significant risk perception with the use of complementary and alternative medicine: A cross-sectional study in Hispanic patients with rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2020)

The added value of musculoskeletal ultrasound to clinical evaluation in the treatment decision of rheumatoid arthritis outpatients: physician experience matters
por: Sifuentes-Cantú, C., et al.
Publicado: (2017)

Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives
por: Burgers, Leonie E, et al.
Publicado: (2019)

Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?
por: Woodburn, James, et al.
Publicado: (2010)

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic ‘window of opportunity’
por: Greisen, Stinne Ravn, et al.
Publicado: (2014)

Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?
por: Bergstra, Sytske Anne, et al.
Publicado: (2020)

Factors Associated With the Quality of the Patient-Doctor Relationship: A Cross-Sectional Study of Ambulatory Mexican Patients With Rheumatic Diseases
por: Pascual-Ramos, Virginia, et al.
Publicado: (2022)

Concordance among patients and physicians about their ideal of autonomy impacts the patient-doctor relationship: A cross-sectional study of Mexican patients with rheumatic diseases
por: Pascual-Ramos, Virginia, et al.
Publicado: (2020)

Response: How to Use a Window of Opportunity
por: Chisolm, Margaret S., et al.
Publicado: (2011)

Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients
por: Roelsgaard, Ida K, et al.
Publicado: (2020)

Pathogenesis of rheumatoid arthritis: how early is early?
por: Firestein, Gary S
Publicado: (2005)

Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice
por: Siddle, Heidi J, et al.
Publicado: (2023)

Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort
por: Kedra, Joanna, et al.
Publicado: (2022)

Window of Opportunity
Publicado: (1996)

Perceived dignity is an unrecognized source of emotional distress in patients with rheumatic diseases: Results from the validation of the Mexican version of the Patient Dignity Inventory
por: Pascual-Ramos, Virginia, et al.
Publicado: (2023)

Co-morbidity in patients with early rheumatoid arthritis - inflammation matters
por: Innala, Lena, et al.
Publicado: (2016)

Weak signal detection: A discrete window of opportunity for achieving ‘Vision 90:90:90’?
por: Burman, Christopher J., et al.
Publicado: (2016)

Cell-based therapies for rheumatoid arthritis: opportunities and challenges
por: Li, Yu-Jing, et al.
Publicado: (2022)

Clinical and bioethical implications of health care interruption during the COVID-19 pandemic: A cross-sectional study in outpatients with rheumatic diseases
por: Guaracha-Basáñez, Guillermo A., et al.
Publicado: (2021)

IL2RA is associated with persistence of rheumatoid arthritis
por: van Steenbergen, H.W., et al.
Publicado: (2015)

Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
por: Machado, Marina Amaral de Ávila, et al.
Publicado: (2016)

Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
por: Mahlich, Jörg, et al.
Publicado: (2016)

Long-term persistence with rituximab in patients with rheumatoid arthritis
por: Oldroyd, Alexander G S, et al.
Publicado: (2018)

Challenges and opportunities for diagnosis and treatment of rheumatoid arthritis in Latin America
por: Pineda, Carlos, et al.
Publicado: (2015)

Calcium-Permeable Channels Cooperation for Rheumatoid Arthritis: Therapeutic Opportunities
por: Liang, Hong-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_imfvu1j1brfchfj7ad5l47421d